These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24375972)

  • 1. Clinical characteristics in patients with interstitial deletions of chromosome region 12q21-q22 and identification of a critical region associated with keratosis pilaris.
    Al-Maawali A; Marshall CR; Scherer SW; Dupuis L; Mendoza-Londono R; Stavropoulos DJ
    Am J Med Genet A; 2014 Mar; 164A(3):796-800. PubMed ID: 24375972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mosaic intragenic microduplication of LAMA1 and a constitutional 18p11.32 microduplication in a patient with keratosis pilaris and intellectual disability.
    Kashevarova AA; Nazarenko LP; Skryabin NA; Nikitina TV; Vasilyev SA; Tolmacheva EN; Lopatkina ME; Salyukova OA; Chechetkina NN; Vorotelyak EA; Kalabusheva EP; Fishman VS; Kzhyshkowska J; Graziano C; Magini P; Romeo G; Lebedev IN
    Am J Med Genet A; 2018 Nov; 176(11):2395-2403. PubMed ID: 30244536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratosis pilaris and ulerythema ophryogenes in a woman with monosomy of the short arm of chromosome 18.
    Carvalho CA; Carvalho AV; Kiss A; Paskulin G; Götze FM
    An Bras Dermatol; 2011; 86(4 Suppl 1):S42-5. PubMed ID: 22068768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-facio-cutaneous syndrome phenotype in an individual with an interstitial deletion of 12q: identification of a candidate region for CFC syndrome.
    Rauen KA; Cotter PD; Bitts SM; Cox VA; Golabi M
    Am J Med Genet; 2000 Jul; 93(3):219-22. PubMed ID: 10925386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of the interstitial 6q25 microdeletion syndrome: refinement of the critical causative region.
    Michelson M; Ben-Sasson A; Vinkler C; Leshinsky-Silver E; Netzer I; Frumkin A; Kivity S; Lerman-Sagie T; Lev D
    Am J Med Genet A; 2012 Jun; 158A(6):1395-9. PubMed ID: 22585544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trias of keratosis pilaris, ulerythema ophryogenes and 18p monosomy: Zouboulis syndrome.
    Liakou AI; Esteves de Carvalho AV; Nazarenko LP
    J Dermatol; 2014 May; 41(5):371-6. PubMed ID: 24801913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 12q21 deletion syndrome: Narrowing the critical region down to 1.6 Mb including SYT1 and PPP1R12A.
    Niclass T; Le Guyader G; Beneteau C; Joubert M; Pizzuti A; Giuffrida MG; Bernardini L; Gilbert-Dussardier B; Bilan F; Egloff M
    Am J Med Genet A; 2020 Sep; 182(9):2133-2138. PubMed ID: 32633079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoglein 4 Mutation Underlies Autosomal Recessive Keratosis Pilaris Atrophicans.
    Cohen-Barak E; Danial-Farran N; Hammad H; Aleme O; Krauz J; Gavish E; Khayat M; Ziv M; Shalev S
    Acta Derm Venereol; 2018 Aug; 98(8):809-810. PubMed ID: 29796690
    [No Abstract]   [Full Text] [Related]  

  • 9. Keratosis pilaris and ulerythema ophryogenes associated with an 18p deletion caused by a Y/18 translocation.
    Nazarenko SA; Ostroverkhova NV; Vasiljeva EO; Nazarenko LP; Puzyrev VP; Malet P; Nemtseva TA
    Am J Med Genet; 1999 Jul; 85(2):179-82. PubMed ID: 10406673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic characterization and genotype/phenotype analysis in a patient with a de novo 8p23.2p23.3 deletion/12p13.31p13.33 duplication.
    Margari L; Di Cosola ML; Buttiglione M; Pansini A; Buonadonna AL; Craig F; Cariola F; Petruzzelli MG; Gentile M
    Am J Med Genet A; 2012 Jul; 158A(7):1713-8. PubMed ID: 22639464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additional patient with del(12)(q21.2q22): further evidence for a candidate region for cardio-facio-cutaneous syndrome?
    Rauen KA; Albertson DG; Pinkel D; Cotter PD
    Am J Med Genet; 2002 Jun; 110(1):51-6. PubMed ID: 12116271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal-array analysis reveals partial 11q duplication and partial 12p deletion in a mildly affected case.
    Tuğ E; Yirmibeş Karaoğuz M; Kayhan G; Ergün MA; Perçin FE
    Am J Med Genet A; 2014 Jul; 164A(7):1770-6. PubMed ID: 24677787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial 1q23.3q24.1 deletion in a patient with renal malformation, congenital heart disease, and mild intellectual disability.
    Mackenroth L; Hackmann K; Klink B; Weber JS; Mayer B; Schröck E; Tzschach A
    Am J Med Genet A; 2016 Sep; 170(9):2394-9. PubMed ID: 27255444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 1q31.2q32.1 deletion in an adult male with intellectual disability, dysmorphic features and obesity.
    Hyder Z; Fairclough A; Douzgou S
    Clin Dysmorphol; 2019 Jul; 28(3):131-136. PubMed ID: 31045593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of 14.7 Mb 2q32.3q33.3 with a marfanoid phenotype and hypothyroidism.
    Tomaszewska A; Podbiol-Palenta A; Boter M; Geisler G; Wawrzkiewicz-Witkowska A; Galjaard RJ; Zajączek S; Srebniak MI
    Am J Med Genet A; 2013 Sep; 161A(9):2347-51. PubMed ID: 23918240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refinement of the deletion in 8q22.2-q22.3: the minimum deletion size at 8q22.3 related to intellectual disability and epilepsy.
    Kuroda Y; Ohashi I; Saito T; Nagai J; Ida K; Naruto T; Iai M; Kurosawa K
    Am J Med Genet A; 2014 Aug; 164A(8):2104-8. PubMed ID: 24801133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo interstitial deletion 2q14.1q22.1: is there a recognizable phenotype?
    Greally MT; Robinson E; Allen NM; O'Donovan D; Crolla JA
    Am J Med Genet A; 2014 Dec; 164A(12):3194-202. PubMed ID: 25263257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo microdeletions of chromosome 6q14.1-q14.3 and 6q12.1-q14.1 in two patients with intellectual disability - further delineation of the 6q14 microdeletion syndrome and review of the literature.
    Becker K; Di Donato N; Holder-Espinasse M; Andrieux J; Cuisset JM; Vallée L; Plessis G; Jean N; Delobel B; Thuresson AC; Annerén G; Ravn K; Tümer Z; Tinschert S; Schrock E; Jønch AE; Hackmann K
    Eur J Med Genet; 2012; 55(8-9):490-7. PubMed ID: 22561202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental delay and facial dysmorphism in a child with an 8.9 Mb de novo interstitial deletion of 3q25.1-q25.32: Genotype-phenotype correlations of chromosome 3q25 deletion syndrome.
    Moortgat S; Verellen-Dumoulin C; Maystadt I; Parmentier B; Grisart B; Hennecker JL; Destree A
    Eur J Med Genet; 2011; 54(2):177-80. PubMed ID: 21167329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3q27.3 microdeletional syndrome: a recognisable clinical entity associating dysmorphic features, marfanoid habitus, intellectual disability and psychosis with mood disorder.
    Thevenon J; Callier P; Poquet H; Bache I; Menten B; Malan V; Cavaliere ML; Girod JP; Thauvin-Robinet C; El Chehadeh S; Pinoit JM; Huet F; Verges B; Petit JM; Mosca-Boidron AL; Marle N; Mugneret F; Masurel-Paulet A; Novelli A; Tümer Z; Loeys B; Lyonnet S; Faivre L
    J Med Genet; 2014 Jan; 51(1):21-7. PubMed ID: 24133203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.